Skip to main content
. Author manuscript; available in PMC: 2018 Oct 29.
Published in final edited form as: Adv Inorg Chem. 2015 Nov 16;68:1–41. doi: 10.1016/bs.adioch.2015.09.001

Figure 6.

Figure 6

Structure of a conjugate of a THP chelator with a ligand that binds to the prostate-specific membrane antigen (PSMA), and nanoPET/CT images showing specific tumor targeting (arrow) in a mouse model of PSMA-expressing prostate cancer.